share_log

Wedbush Downgrades Avrobio to Neutral, Announces $2 Price Target

Benzinga ·  Jul 12, 2023 11:40

Wedbush analyst David Nierengarten downgrades Avrobio (NASDAQ:AVRO) from Outperform to Neutral and announces $2 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment